From acquisitions to FDA nods, here are 11 recent updates from Stryker.
1. Stryker CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO.
2. Stryker was included on Fortune’s annual list of the World’s Most Admired Companies, which was released Jan. 29.
3. Stryker board of directors member Allan Golston plans to retire from his post following 14 years with the company.
4. Stryker completed its acquisition of Inari Medical about a month after announcing the deal in January.
5. Stryker has elevated Kim Montagnino to chief communications officer.
6. Stryker CEO Kevin Lobo’s total compensation grew from $20.8 million in 2023 to just under $22 million in 2024, according to a March 25 Securities and Exchange Commission proxy filing.
7. Investment firm Viscogliosi Brothers completed its acquisition of Stryker’s U.S. spine business. The acquisition was initially announced in January.
8. MemorialCare is the first hospital in the world to complete a robotic hip revision using Stryker’s Mako Total Hip system with 5.0 Advanced Primary and Revision application. It was also the first hospital in California to use the Mako 4 SmartRobotics system in conjunction with Stryker’s Q Guidance System.
9. Stryker saw year-over-year revenue growth in the first quarter of 2025. Orthopedic sales grew 9.7% year over year to $2.3 billion, and med-surg and neurotechnology sales grew 13.4% to $3.5 billion.
10. Stryker plans to absorb the impact of tariffs, an estimated $200 million cost, Vice President and CFO Preston Wells said in a May 1 quarterly earnings call.
11. Stryker’s OptaBlate, the company’s first basivertebral nerve ablation system earned FDA 510(k) clearance.
